What is the difference between a multiple sclerosis (MS) flare and a pseudoflare in terms of diagnosis and treatment?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 7, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

MS Flare vs. Pseudoflare: Diagnosis and Treatment

A pseudoflare in multiple sclerosis is a temporary worsening of existing MS symptoms due to external factors like infection or temperature changes, while a true MS flare represents new inflammatory demyelinating activity requiring different treatment approaches. 1

Diagnostic Differences

True MS Flare (Exacerbation/Relapse)

  • Represents a genuine episode of neurological disturbance caused by inflammatory and demyelinating lesions 1
  • Must last for at least 24 hours to be classified as a true attack 1
  • Involves new symptoms or worsening of existing symptoms that cannot be attributed to other causes 1
  • Requires objective clinical findings of a new lesion for diagnosis 1
  • Often shows evidence of new or enhancing lesions on MRI 1
  • Separate attacks must be at least 30 days apart to be considered distinct events 1

Pseudoflare (Pseudoattack)

  • Temporary worsening of existing MS symptoms without new inflammatory activity 1
  • Commonly triggered by external factors such as:
    • Increased core body temperature (heat sensitivity) 1
    • Infection 1
    • Stress 2
    • Fatigue 3
  • Does not represent new disease activity or progression 1
  • MRI typically shows no new or enhancing lesions 1
  • Symptoms typically resolve when the triggering factor is addressed 1

Key Diagnostic Tools

Clinical Assessment

  • Thorough neurological examination to determine if symptoms represent new deficits or exacerbation of existing ones 1
  • Assessment for potential triggers of pseudoflares (infection, fever, stress) 1
  • Evaluation of symptom duration (must be at least 24 hours for a true flare) 1

MRI Imaging

  • Critical for distinguishing between flare and pseudoflare 1
  • True flares often show:
    • New T2 hyperintense lesions 1
    • Gadolinium-enhancing lesions indicating active inflammation 1
  • Standardized MRI protocols should include:
    • Pre-contrast T1-weighted sequences 1
    • Dual-echo T2-weighted sequences 1
    • Post-gadolinium T1-weighted sequences 1
    • Fluid-attenuated inversion recovery (FLAIR) sequences 1

Additional Diagnostic Tests

  • Cerebrospinal fluid analysis may be helpful in atypical presentations 1
  • Visual evoked potentials can provide additional support in cases with few MRI abnormalities 1
  • Laboratory tests to rule out infection or other causes of symptom worsening 1

Treatment Approaches

True MS Flare Treatment

  • Corticosteroids are the mainstay of treatment for acute exacerbations 2, 4
  • Standard regimen: high-dose methylprednisolone (equivalent to 200 mg prednisolone daily for a week followed by 80 mg every other day for a month) 2
  • Plasmapheresis may be considered for patients who don't respond adequately to steroids 4
  • Evaluation for adjustment of disease-modifying therapy may be necessary 4

Pseudoflare Management

  • Identify and treat the underlying trigger rather than using MS-specific treatments 1
  • For infection-related pseudoflares: appropriate antimicrobial therapy 1
  • For temperature-related pseudoflares: cooling strategies 3
  • For stress-related pseudoflares: stress management techniques 2
  • Symptomatic treatment of specific symptoms (e.g., fatigue, spasticity) 5
  • Corticosteroids are typically not indicated for pseudoflares 2

Clinical Pitfalls and Caveats

  • Misdiagnosing a pseudoflare as a true relapse can lead to unnecessary steroid treatment with potential side effects 2
  • Conversely, misinterpreting a true flare as a pseudoflare may delay appropriate treatment 1
  • Some patients may experience both a true flare and concurrent factors that worsen symptoms (e.g., infection triggering both inflammation and pseudoflare symptoms) 1
  • The distinction between flare and pseudoflare is critical for:
    • Appropriate treatment decisions 2
    • Accurate assessment of disease activity and progression 3
    • Evaluation of treatment efficacy 4
  • MRI findings must be interpreted in clinical context, as some patients with true flares may not show new MRI activity 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Multiple Sclerosis: A Primary Care Perspective.

American family physician, 2022

Research

Overview of symptomatic management of multiple sclerosis.

The Journal of neuroscience nursing : journal of the American Association of Neuroscience Nurses, 2001

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.